Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Rosiglitazone on Renal Hemodynamics and Proteinuria of Type 2 Diabetic Patients With Renal Insufficiency Due to Overt Diabetic Nephropathy

NCT00324675 is registered in ClinicalTrials.gov with Technische Universität Dresden as lead sponsor.

NCT NCT00324675
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00324675 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Rosiglitazone on Renal Hemodynamics and Proteinuria of Type 2 Diabetic Patients With Renal Insufficiency Due to Overt Diabetic Nephropathy
Lead sponsor
Technische Universität Dresden
Phase
Not applicable
Overall status
Completed
Start date
August 31, 2006
Completion date
December 31, 2010
Enrollment
28 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

overt diabetic nephropathy, type 2 diabetes